Indomethacin and fetal ductus arteriosus: complete closure after cessation of prolonged therapeutic course.
Indomethacin is a very effective tocolytic agent. However, concern about its possible constrictive effect on fetal ductus arteriosus has limited the use of this medication in pregnancy. A 29-year-old woman was treated with indomethacin at 27 weeks of gestation for preterm labor and polyhydramnios. She received a dose of 75 mg/day for 5 weeks. At 35 weeks of gestation, she had a cesarean delivery due to fetal distress, and a hydropic baby was delivered. The infant died shortly after. Nonimmune hydrops fetalis and closed ductus arteriosus were the only pathological findings at autopsy. In utero, irreversible, complete closure of the ductus arteriosus is very rare. In the case presented, prolonged use of indomethacin during pregnancy was associated with complete closure of the ductus arteriosus that developed most probably after discontinuation of therapy. This case emphasizes the need for frequent fetal echocardiography examinations during as well as after maternal indomethacin treatment.
Ben-David
Y
Y
Department of Obstetrics and Gynecology, Carmel Medical Center, Haifa, Israel.
Hallak
M
M
Rotschild
A
A
Sorokin
Y
Y
Auslender
R
R
Abramovici
H
H
D000328:Adult; D003251:Constriction, Pathologic / Q000139:chemically induced; D004373:Ductus Arteriosus / Q000473:pathology; D005260:Female; D006801:Humans; D015160:Hydrops Fetalis / Q000209:etiology; D007213:Indomethacin / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D007752:Obstetric Labor, Premature / Q000188:drug therapy*; D006831:Polyhydramnios / Q000188:drug therapy; D011247:Pregnancy
D007213:Indomethacin